Utilizing the A3 adenosine receptor agonist CF101 for the treatment of autoimmune inflammatory indications: data from advanced clinical studies

PURINERGIC SIGNALLING(2014)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要